Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene

Thyroid

Volumn 7, Issue 5, 1997, Pages 765-770

  Kopp, Peter ^a   Jameson, J Larry ^a   Roe, Thomas F ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; THYROTROPIN RECEPTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; FEMALE; GENE MUTATION; HUMAN; HYPERTHYROIDISM; MENTAL DEFICIENCY; PRIORITY JOURNAL; PSYCHOMETRY; RECEPTOR GENE; THYROID DISEASE; TWINS;

EID: 0031406420     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.765     Document Type: Article

References (43)

1. Ramsay I, Kaur S, Krassas G 1983 Thyrotoxicosis in pregnancy: Results of treatment by antithyroid drugs combined with T4. Clin Endocrinol (Oxf) 18:73-85.
2. Thomas R, Reid R 1987 Thyroid disease and reproductive dysfunction. A review. Obstet Gynecol 70:789-798.
3. Ochsner A, Thomson R 1910 The Surgery and Pathology of the Thyroid and Parathyroid Glands. CV Mosby Co, St. Louis, p 192.
4. McKenzie J 1964 Neonatal Graves' disease. J Clin Endocrinol 24:660-668.
5. Sunshine P, Kusumoto H, Kriss J 1965 Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: Implications for diagnosis and therapy of the disorder. Pediatrics 36:869-876.
6. Dirmikis S, Munro D, Hiller E, Crawford M, Wynne J, Purcell M 1974 Placental transmission of LATS-protector. Lancet 2:1579-1580.
7. Nutt J, Clark F, Welch R, Hall R 1974 Neonatal hyperthyroidism and long-acting thyroid stimulator protector. Br Med J 4:695-696.
8. Thomson J, Dirmikis S, Munro D, Smith B, Hall R, Mukhtar E 1975 Neonatal hyperthyroidism and long-acting thyroid stimulator protector. Br Med J 2:36.
9. McKenzie J, Zakarija M 1978 Pathogenesis of neonatal Graves' disease. J Endocrinol Invest 2:183-189.
10. Zakarija M, McKenzie J 1983 Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 57:1036-1040.
11. Vassart G, Dumont J 1992 The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13:596-611.
12. Zakarija M, McKenzie J, Munro D 1983 Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves disease. J Clin Invest 72:1352-1356.
13. Zakarija M, McKenzie J, Hoffmann W 1986 Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. J Clin Endocrinol Metab 62:368-371.
14. Fort P, Lifshitz F, Pugliese M, Klein I 1988 Neonatal thyroid disease: Differential expression in three successive offsprings. J Clin Endocrinol Metab 66:645-647.
15. Wilroy RJ, Etteldorf J 1971 Familial hyperthyroidism including two siblings with neonatal Graves' disease. J Pediatr 78:625-632.
16. Hollingsworth D, Mabry C, Eckerd J 1972 Hereditary aspects of Graves' disease in infancy and childhood. J Pediatr 81:446-459.
17. Hollingsworth D, Mabry C 1976 Congenital Graves disease: Four familial cases with long-term follow-up and perspective. Am J Dis Child 130:148-155.
18. Hollingsworth D, Mabry C, Reid M 1980 New observations in congenital Graves' disease. In: Stockigt J, Nagataki S (eds) Thyroid research VIII: proceedings of the Eighth International Thyroid Congress, Sydney, Australia. Pergamon Press, Oxford, pp 587-590.
19. Hollingsworth D, Mabry C, Reid M 1980 Congenital Graves' disease. In: La Cauza C, Root A (eds). Problems in Pediatric Endocrinology: Proceedings of the Serono Symposia. Academic Press, London, pp. 169-191.
20. Hollingsworth DR. Neonatal hyperthyroidism 1985 In: Delange F, Fisher DA, Malvaux P (eds). Pediatric Thyroidology. Basel, Karger, pp. 210-222.
21. Horton G 1987 Hyperthyroidie héreditaire par hyperactivité diffuse non-autoimmune de la thyroide avec autonomie de fonction et de croissance. University of Lausanne.
22. Zannolli R, Breda L, Rosati E, Chiarelli F 1989 Ipertiroidismo neonatale ad insorgenza precoce ed a decorso protratto. Min Ped 41:33-40.
23. Kopp P, van Sande J, Parma J, Duprez L, Gerber H, Joss E, Jameson JL, Dumont JE, Vassart, G 1995 Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 332:150-154.
24. Thomas J, Leclère J, Hartemann P, Duheille J, Orgiazzi J, Petersen M, Janot C, Guedenet JC 1982 Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol 100:512-518.
25. De Roux N, Polak M, Couet J, Legher J, Czernichow P, Milgrom E, Misrahi M 1996 A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab 81:2023-2026.
26. Parma J, Duprez L, van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 356:649-651.
27. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Awedimento V 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 79:657-661.
28. Paschke R, Tonacchera M, van Sande J, Parma J, Vassart G 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab 79:1785-1789.
29. 2+ cascades. Mol Endocrinol 9:725-733.
30. Duprez L, Parma J, van Sande J, Allgeier A, Leclère J, Schvartz C, Delisle M-J, Decoulx M, Orgiazzi J, Dumont J, Vassart G 1994 Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nature Genetics 7:396-401.
31. Kosugi S, Shenker A, Mori T 1994 Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor. FEBS Lett 356:291-294.
32. American Psychiatric Association 1987 Diagnostic and Statistical Manual of Mental Disorders, Third edition, revised. American Psychiatric Association, Washington, D.C.
33. Kremer H, Mariman E, Otten B, Moll GW, Stoelinga GBA, Wit JM, Jansen M, Drop SL, Faas B, Ropers HH, Brunner HG 1993 Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Molec Genet 2:1779-1783.
34. Shenker A, Laue L, Kosugi S, Merendino JJ, Minegishi T, Cutler GJ 1993 A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652-654.
35. Yano K, Hidaka A, Saji M, Polymeropoulos MH, Okundo A, Kohn LD, Cutler GB Jr 1994 A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor as familial cases. J Clin Endocrinol Metab 79:1818-1823.
36. Kraaij R, Post M, Kremer H, Milgrom E, Epping W, Brunner HG, Grootegoed JA, Themmen APN 1995 A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab 80:3168-3172.
37. 2+-sensing receptor gene mutation. Nature Genet 8:303-307.
38. Shipani E, Kruse K, Jüppner H 1995 A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal receptor gene mutation. Science 268:98-100.
39. Hauser P, Zametkin AJ, Martinez P, Vitiello B, Matochik JA, Mixson AJ, Weintraub BD 1993 Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 328:997-1001.
40. Kopp P, Kitajima K, Jameson J 1996 Syndrome of resistance to thyroid hormone: Insights into thyroid hormone action. Proc Soc Exp Biol Med 211:49-61.
41. Vassart G, Parma J, van Sande J, Dumont J 1994 The thyrotropin receptor and the regulation of thyrocyte function and growth: Update 1994. Endocr Rev 3:77-80.
42. Tonacchera M, van Sande J, Cetani F, Swillens S, Schvartz C, Winizewski P, Portmann L, Dumont JE, Vassart G, Parma J 1996 Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 81:547-554.
43. Kopp P, Muirhead S, Jourdain N, Gu WX, Jameson JL, Rodd C 1997 Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine 281 to isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 100: in press